MARKET WIRE NEWS
  1. Home
  2. Stock
  3. VCNX
  4. News
VCNX
Quote
Short
News
Articles
Message Board

Vaccinex Inc. (OTCMKTS : VCNX ) News

News Releases

VCNX News Releases
VCNX : OTC
SeekingAlpha
Vaccinex GAAP EPS of -$1.97, revenue of $2.09M
VCNX : OTC
GlobeNewswire
Vaccinex Reports 2025 Annual Financial Results
VCNX : NASDAQ
AllPennyStocks.com
Micro Cap Biotech Secures $60M to Advance Alzheimer's Treatment, Shares Surge
VCNX : NASDAQ
GlobeNewswire
Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer's Disease
VCNX : NASDAQ
GlobeNewswire
Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting
VCNX : NASDAQ
GlobeNewswire
Vaccinex to Report Promising New Clinical Data Revealing Pepinemab's Unique Mechanism to Enhance Immunotherapy at Annual Meeting of American Association for Cancer Research (AACR)
VCNX : NASDAQ
SeekingAlpha
Vaccinex plans to delist common stock from Nasdaq
VCNX : NASDAQ
GlobeNewswire
Vaccinex Plans to Delist its Common Stock from The Nasdaq Stock Market

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.